These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29945890)

  • 1. Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes.
    Anquetil F; Mondanelli G; Gonzalez N; Rodriguez Calvo T; Zapardiel Gonzalo J; Krogvold L; Dahl-Jørgensen K; Van den Eynde B; Orabona C; Grohmann U; von Herrath MG
    Diabetes; 2018 Sep; 67(9):1858-1866. PubMed ID: 29945890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset.
    Rodriguez-Calvo T; Zapardiel-Gonzalo J; Amirian N; Castillo E; Lajevardi Y; Krogvold L; Dahl-Jørgensen K; von Herrath MG
    Diabetes; 2017 May; 66(5):1334-1345. PubMed ID: 28137793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
    Orabona C; Mondanelli G; Pallotta MT; Carvalho A; Albini E; Fallarino F; Vacca C; Volpi C; Belladonna ML; Berioli MG; Ceccarini G; Esposito SM; Scattoni R; Verrotti A; Ferretti A; De Giorgi G; Toni S; Cappa M; Matteoli MC; Bianchi R; Matino D; Iacono A; Puccetti M; Cunha C; Bicciato S; Antognelli C; Talesa VN; Chatenoud L; Fuchs D; Pilotte L; Van den Eynde B; Lemos MC; Romani L; Puccetti P; Grohmann U
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized Mouse Model to Study Type 1 Diabetes.
    Luce S; Guinoiseau S; Gadault A; Letourneur F; Blondeau B; Nitschke P; Pasmant E; Vidaud M; Lemonnier F; Boitard C
    Diabetes; 2018 Sep; 67(9):1816-1829. PubMed ID: 29967002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Insulitic Profiles Determine the Extent of β-Cell Destruction and the Age at Onset of Type 1 Diabetes.
    Leete P; Willcox A; Krogvold L; Dahl-Jørgensen K; Foulis AK; Richardson SJ; Morgan NG
    Diabetes; 2016 May; 65(5):1362-9. PubMed ID: 26858360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.
    Benkahla MA; Sabouri S; Kiosses WB; Rajendran S; Quesada-Masachs E; von Herrath MG
    J Autoimmun; 2021 May; 119():102628. PubMed ID: 33706238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.
    Subauste A; Gianani R; Chang AM; Plunkett C; Pietropaolo SL; Zhang YJ; Barinas-Mitchell E; Kuller LH; Galecki A; Halter JB; Pietropaolo M
    PLoS One; 2014; 9(9):e106537. PubMed ID: 25226365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.
    James EA; Pietropaolo M; Mamula MJ
    Diabetes; 2018 Jun; 67(6):1035-1042. PubMed ID: 29784651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
    Rajendran S; Quesada-Masachs E; Zilberman S; Graef M; Kiosses WB; Chu T; Benkahla MA; Lee JM; von Herrath M
    J Autoimmun; 2021 Sep; 123():102708. PubMed ID: 34358764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice.
    Parsa R; Andresen P; Gillett A; Mia S; Zhang XM; Mayans S; Holmberg D; Harris RA
    Diabetes; 2012 Nov; 61(11):2881-92. PubMed ID: 22745325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
    Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
    Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNAs in islet beta-cell compensation and failure during diabetes.
    Plaisance V; Waeber G; Regazzi R; Abderrahmani A
    J Diabetes Res; 2014; 2014():618652. PubMed ID: 24734255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease.
    Reddy S; Krogvold L; Martin C; Holland R; Choi J; Woo H; Wu F; Dahl-Jørgensen K
    Diabetologia; 2018 Jun; 61(6):1362-1373. PubMed ID: 29589071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U; Kimmel R
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity and Lobularity of Pancreatic Pathology in Type 1 Diabetes during the Prediabetic Phase.
    Rodriguez-Calvo T; Suwandi JS; Amirian N; Zapardiel-Gonzalo J; Anquetil F; Sabouri S; von Herrath MG
    J Histochem Cytochem; 2015 Aug; 63(8):626-36. PubMed ID: 26216138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease.
    Jaberi-Douraki M; Liu SW; Pietropaolo M; Khadra A
    Pediatr Diabetes; 2014 May; 15(3):162-74. PubMed ID: 24827702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
    Dotta F; Eisenbarth GS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes.
    Yoneda S; Uno S; Iwahashi H; Fujita Y; Yoshikawa A; Kozawa J; Okita K; Takiuchi D; Eguchi H; Nagano H; Imagawa A; Shimomura I
    J Clin Endocrinol Metab; 2013 May; 98(5):2053-61. PubMed ID: 23539729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.
    Campbell-Thompson M; Fu A; Kaddis JS; Wasserfall C; Schatz DA; Pugliese A; Atkinson MA
    Diabetes; 2016 Mar; 65(3):719-31. PubMed ID: 26581594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced β-cell function in early preclinical type 1 diabetes.
    Koskinen MK; Helminen O; Matomäki J; Aspholm S; Mykkänen J; Mäkinen M; Simell V; Vähä-Mäkilä M; Simell T; Ilonen J; Knip M; Veijola R; Toppari J; Simell O
    Eur J Endocrinol; 2016 Mar; 174(3):251-9. PubMed ID: 26620391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.